This study is in progress, not accepting new patients
Multiple Doses of AT-1501-A201 in Adults With ALS
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Orange, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Anelixis Therapeutics, LLC
- ID
- NCT04322149
- Phase
- Phase 2 Amyotropic Lateral Sclerosis (ALS) Research Study
- Study Type
- Interventional
- Participants
- Expecting 54 study participants
- Last Updated